Protalix BioTherapeutics, Inc. Inventory, Finished Goods, Gross
Protalix BioTherapeutics, Inc. (PLX) had Inventory, Finished Goods, Gross of $4.86 million as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2013-11-07
- 2013-09-30: Inventory, Finished Goods, Gross $4.86M.
- 2013-06-30: Inventory, Finished Goods, Gross $4.36M.
- 2013-03-31: Inventory, Finished Goods, Gross $3.01M.
- 2012-12-31: Inventory, Finished Goods, Gross $1.73M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2013-09-30 | $4.86M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $4.36M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.01M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.73M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |